BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27888882)

  • 1. The Challenge of Primary Central Nervous System Lymphoma.
    Carnevale J; Rubenstein JL
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1293-1316. PubMed ID: 27888882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of primary central nervous system lymphoma.
    Glass J
    Chin Clin Oncol; 2017 Aug; 6(4):38. PubMed ID: 28841800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical Therapeutic Efficacy of Rituximab Combined with Methotrexate on Primary Central Nervous System Lymphoma].
    Luo W; Ji LH; Geng H; Ma XJ; Xiong H; Yin QC; Yin YJ; Yu L; Ma J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):444-7. PubMed ID: 27151007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary central nervous system lymphoma: essential points in diagnosis and management.
    Paydas S
    Med Oncol; 2017 Apr; 34(4):61. PubMed ID: 28315229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary central nervous lymphoma: what is the role for radiotherapy?].
    Bellefqih S; Mezouri I; Khalil J; Bazine A; Diakité A; El Kacimi H; Kebdani T; Benjaafar N
    Cancer Radiother; 2014 Nov; 18(7):685-92. PubMed ID: 25451676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of primary central nervous system lymphoma.
    Han CH; Batchelor TT
    Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Beam Therapy for Adolescent Primary Central Nervous System Lymphoma With Residual Tumor After Intensive Chemotherapy: A Case Report.
    Komori K; Saito S; Araya M; Morita D; Kurata T; Hirabayashi K; Tanaka M; Koiwai K; Tauchi K; Masaki H; Nakazawa Y
    Pract Radiat Oncol; 2019; 9(5):333-337. PubMed ID: 31128305
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab with high-dose methotrexate in primary central nervous system lymphoma.
    Kansara R; Shenkier TN; Connors JM; Sehn LH; Savage KJ; Gerrie AS; Villa D
    Am J Hematol; 2015 Dec; 90(12):1149-54. PubMed ID: 26414492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary CNS lymphoma. Progress in the diagnostics and therapy].
    Korfel A; Schlegel U
    Nervenarzt; 2015 Jun; 86(6):710-2, 714-5. PubMed ID: 26013534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary non-Hodgkin's lymphoma of the brain revisited.
    Mwangemi PM
    East Afr Med J; 1991 Mar; 68(3):190-6. PubMed ID: 2070754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central Nervous System Lymphomas.
    Grommes C
    Continuum (Minneap Minn); 2020 Dec; 26(6):1476-1494. PubMed ID: 33273169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
    Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in primary CNS lymphoma.
    Abrey LE
    Expert Rev Neurother; 2005 Jul; 5(4):459-64. PubMed ID: 16026229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology of CNS lymphoma and the potential of novel agents.
    Rubenstein JL
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):556-564. PubMed ID: 29222305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system lymphoma: overview of current treatment strategies.
    Brastianos PK; Batchelor TT
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):897-916. PubMed ID: 22794289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches in primary central nervous system lymphoma.
    Fraser E; Gruenberg K; Rubenstein JL
    Chin Clin Oncol; 2015 Mar; 4(1):11. PubMed ID: 25841718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
    Ferreri AJ; Reni M; Foppoli M; Martelli M; Pangalis GA; Frezzato M; Cabras MG; Fabbri A; Corazzelli G; Ilariucci F; Rossi G; Soffietti R; Stelitano C; Vallisa D; Zaja F; Zoppegno L; Aondio GM; Avvisati G; Balzarotti M; Brandes AA; Fajardo J; Gomez H; Guarini A; Pinotti G; Rigacci L; Uhlmann C; Picozzi P; Vezzulli P; Ponzoni M; Zucca E; Caligaris-Cappio F; Cavalli F;
    Lancet; 2009 Oct; 374(9700):1512-20. PubMed ID: 19767089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary lymphoma of the nervous system.
    Baehring JM; Hochberg FH
    Cancer J; 2006; 12(1):1-13. PubMed ID: 16613654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary non-Hodgkin lymphomas of the central nervous system].
    Hutschenreuter M; Wildemann B; Schackert G; Herrmann R; Hacke W
    Nervenarzt; 1991 Feb; 62(2):69-79. PubMed ID: 2034311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.